CMS

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Under the LCD, pharmacogenomic tests are covered when medications are being considered for use that are known to have a clinically actionable gene-drug interaction.

The decision comes after Myriad requested expanded coverage for women with breast cancer seeking information about extending endocrine therapy.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

The reimbursement rates for the most commonly performed SARS-CoV-2 serologic tests are $42.13 and $45.23, depending on the billing code used.

The changes include who can order tests for beneficiaries, who can bill CMS for certain testing-related services, and the inclusion of antibody tests as a covered service.

The Medicare Administrative Contractor's decision covers molecular diagnostic laboratory tests as predictive classifiers for non-small cell lung cancer.

The PCR tests are being requested more often during the SARS-CoV-2 pandemic to rule out patients with other viral respiratory conditions.